NCM
GCVRZ

Nelson Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Nelson Capital Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-48
Closed – – 274
2015
Q2 		$0 Hold
48
– – ﹤0.01% 290
2015
Q1 		$0 Hold
48
– – ﹤0.01% 330
2014
Q4 		$0 Hold
48
– – ﹤0.01% 330
2014
Q3 		$0 Buy
+48
New +$23 ﹤0.01% 336

Other funds holding GCVRZ

WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Nelson Capital Management's GCVRZ Position: Q3 2015 in Review

Nelson Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2015, closing a stake of 48 shares.

Nelson Capital Management first reported a position in GCVRZ in Q3 2014 and held it in 4 quarters. The position peaked at $0 in Q2 2015. 117 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2015.

  • Nelson Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q3 2015 after selling out during the quarter.
  • Nelson Capital Management sold 48 Sanofi Contingent Value Rights shares in Q3 2015.
  • Nelson Capital Management first reported a position in Sanofi Contingent Value Rights in Q3 2014 and held it in 4 quarters.
  • Nelson Capital Management's Sanofi Contingent Value Rights position peaked at $0 in Q2 2015.
  • 117 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2015.

Based on Nelson Capital Management's 13F filing for Q3 2015, filed 22 Oct 2015.